Koa Shoji Holdings (9273) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
17 Sep, 2026Market valuation and capital efficiency
PBR at FYE6/2026 was 1.02x, with share price and net asset value per share both rising, but PBR stagnating due to parallel growth.
PER remains lower than sector averages, highlighting the need to strengthen shareholder returns and IR activities.
ROE for FYE6/2026 was 12.6%, consistently above the estimated cost of equity (8–10%).
Financial leverage and net profit margin have been maintained at healthy levels, supporting capital efficiency.
Strategic and financial targets
Medium-term plan targets ROE of 12% or higher through FYE6/2028, with further improvement aimed for FYE6/2030.
Operating profit target of ¥8.0 billion and consolidated net sales of ¥40 billion by FYE6/2030.
Growth driven by expanding API segment and early operation of Zao Factory 2.
Initiatives to enhance valuation and shareholder value
Focus on improving both ROE and PER to enhance PBR through execution of medium- and long-term plans.
Strategic investments in new products, facility upgrades, and sustainability initiatives such as GHG reduction and supply chain improvements.
Strengthened IR structure and enhanced disclosure to foster market expectations.
Latest events from Koa Shoji Holdings
- Record sales and profit driven by API growth; Zao Factory 2 to expand syringe output.9273
Q4 2026 - Modest profit growth, strong cash flow, and a positive FY2025 outlook amid stable operations.9273
Q4 2024 - Net sales fell 13.7% year-over-year, but profit attributable to owners rose 4.9%.9273
Q1 2025 - Strong profit and sales growth achieved, with positive outlook for the full year.9273
Q2 2025 - Sales and profit rose year-over-year, with operating margin and dividend forecast both increased.9273
Q3 2025 - Record sales and profit growth, with major facility investments supporting future expansion.9273
Q4 2025 - API-driven growth boosted sales and profits, with positive outlook and rising dividends.9273
Q1 2026 - API-driven growth offset tablet competition; dividend raised, outlook remains strong.9273
Q2 2026 - API-driven growth and higher dividends offset tablet competition, with robust outlook ahead.9273
Q3 2026